Cargando…

Molecular Biomarkers for Adrenoleukodystrophy: An Unmet Need

X-linked adrenoleukodystrophy (ALD) is an inherited progressive neurometabolic disease caused by mutations in the ABCD1 gene and the accumulation of very long-chain fatty acids in plasma and tissues. Patients present with heterogeneous clinical manifestations which can include adrenal insufficiency,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honey, Madison I. J., Jaspers, Yorrick R. J., Engelen, Marc, Kemp, Stephan, Huffnagel, Irene C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699919/ https://www.ncbi.nlm.nih.gov/pubmed/34943935 http://dx.doi.org/10.3390/cells10123427

Ejemplares similares

Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2020)

Postural Body Sway as Surrogate Outcome for Myelopathy in Adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2020)

Spinal cord atrophy as a measure of severity of myelopathy in adrenoleukodystrophy
por: van de Stadt, Stephanie I. W., et al.
Publicado: (2020)

Disease progression in women with X-linked adrenoleukodystrophy is slow
por: Huffnagel, Irene C., et al.
Publicado: (2019)

Evolution of adrenoleukodystrophy model systems
por: Montoro, Roberto, et al.
Publicado: (2021)

Optical coherence tomography to measure the progression of myelopathy in adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2021)

Magnetic resonance spectroscopy as marker for neurodegeneration in X-linked adrenoleukodystrophy
por: van de Stadt, Stephanie I.W., et al.
Publicado: (2021)

Optical coherence tomography shows neuroretinal thinning in myelopathy of adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2019)

Sex‐specific newborn screening for X‐linked adrenoleukodystrophy
por: Albersen, Monique, et al.
Publicado: (2022)

Correction to: Optical coherence tomography shows neuroretinal thinning in myelopathy of adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2020)

Overall intact cognitive function in male X-linked adrenoleukodystrophy adults with normal MRI
por: Buermans, Noortje J. M. L., et al.
Publicado: (2019)

Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012)

Attitudes of Patients with Adrenoleukodystrophy towards Sex-Specific Newborn Screening
por: Yska, Hemmo A. F., et al.
Publicado: (2023)

Structure and Function of the ABCD1 Variant Database: 20 Years, 940 Pathogenic Variants, and 3400 Cases of Adrenoleukodystrophy
por: Mallack, Eric J., et al.
Publicado: (2022)

Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor
por: Barendsen, Rinse W., et al.
Publicado: (2020)

X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management
por: Engelen, Marc, et al.
Publicado: (2012)

Corrigendum: Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor
por: Barendsen, Rinse W., et al.
Publicado: (2021)

C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man
por: van de Beek, Malu-Clair, et al.
Publicado: (2016)

International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach
por: Engelen, Marc, et al.
Publicado: (2022)

Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy
por: Orchard, Paul J, et al.
Publicado: (2011)

Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy
por: Orchard, Paul J., et al.
Publicado: (2019)

Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2023)

Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders
por: Jaspers, Yorrick R. J., et al.
Publicado: (2020)

Unmet needs in asthma
por: Gruffydd-Jones, Kevin
Publicado: (2019)

Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation
por: Engelen, Marc, et al.
Publicado: (2012)

Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury
por: van Duijl, T. T., et al.
Publicado: (2021)

Pathophysiology of X-linked adrenoleukodystrophy()
por: Berger, J., et al.
Publicado: (2014)

Practical guide for identifying unmet clinical needs for biomarkers
por: Monaghan, Phillip J., et al.
Publicado: (2018)

X-Linked Adrenoleukodystrophy: Molecular and Functional Analysis of the ABCD1 Gene in Argentinean Patients
por: Amorosi, Cyntia Anabel, et al.
Publicado: (2012)

Multi-Omic Approach to Identify Phenotypic Modifiers Underlying Cerebral Demyelination in X-Linked Adrenoleukodystrophy
por: Richmond, Phillip A., et al.
Publicado: (2020)

Unmet needs in rheumatoid arthritis
por: Moreland, Larry
Publicado: (2005)

Unmet needs in the management of schizophrenia
por: Torres-González, Francisco, et al.
Publicado: (2014)

A Tanzanian Boy with Molecularly Confirmed X-Linked Adrenoleukodystrophy
por: Dekker, M. C. J., et al.
Publicado: (2019)

Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs
por: Kaiser, Michael, et al.
Publicado: (2023)

Monitoring for and Management of Endocrine Dysfunction in Adrenoleukodystrophy
por: Kachwala, Isha, et al.
Publicado: (2022)

Unmet psychosocial needs in CAPS
por: Erbis, G, et al.
Publicado: (2015)

Ocular Delivery of Polyphenols: Meeting the Unmet Needs
por: Krstić, Luna, et al.
Publicado: (2021)

Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice
por: Pisani, Laura Francesca, et al.
Publicado: (2017)

Unmet needs of bipolar disorder patients
por: Hajda, Miroslav, et al.
Publicado: (2016)

Addressing unmet needs in the treatment of COPD
por: Patalano, Francesco, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ncaql06qfui3rsdvc4cc2v4trs